The Ejc Supplements is reputed journal publishes research related to cancer, translational oncology, clinical oncology, cancer epidemiology, cancer prevention. The ISSN of the journal is 1878-1217.
Through this web page, researchers can check the indexing, publication fee, journal quartile, and journal aim & scope.
| Journal Title | EJC Supplements |
|---|---|
| Publisher | Elsevier |
| Publication Country | United Kingdom |
| ISSN | 1878-1217 |
| Publication Area | Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
| Publication Language | English |
| Review Process | Anonymous peer review |
| Scopus Indexed | No |
The Ejc Supplements is indexed in: DOAJ, PubMed.
There is a fee to publish in the Ejc Supplements. The publication fee is 3000 USD.
The journal also offers a fee waiver policy.
The Ejc Supplements takes an average of 9 weeks to publish research papers.
The official website of the journal is https://www.journals.elsevier.com/european-journal-of-cancer-supplement.
Please visit only official website of the journal to submit research papers.